- Home
- VRSK vs DXCM Comparison
VRSK vs DXCM Comparison
Compare VRSK & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRSK
- DXCM
- Stock Information
- Founded
- VRSK 1971
- DXCM 1999
- Country
- VRSK United States
- DXCM United States
- Employees
- VRSK N/A
- DXCM N/A
- Industry
- VRSK Business Services
- DXCM Medical/Dental Instruments
- Sector
- VRSK Consumer Discretionary
- DXCM Health Care
- Exchange
- VRSK Nasdaq
- DXCM Nasdaq
- Market Cap
- VRSK 37.5B
- DXCM 31.7B
- IPO Year
- VRSK 2009
- DXCM 2005
- Fundamental
- Price
- VRSK $245.33
- DXCM $75.78
- Analyst Decision
- VRSK Hold
- DXCM Strong Buy
- Analyst Count
- VRSK 11
- DXCM 19
- Target Price
- VRSK $308.09
- DXCM $99.89
- AVG Volume (30 Days)
- VRSK 1.0M
- DXCM 4.7M
- Earning Date
- VRSK 10-29-2025
- DXCM 10-23-2025
- Dividend Yield
- VRSK 0.73%
- DXCM N/A
- EPS Growth
- VRSK 5.36
- DXCM N/A
- EPS
- VRSK 6.48
- DXCM 1.43
- Revenue
- VRSK $2,986,500,000.00
- DXCM $4,300,800,000.00
- Revenue This Year
- VRSK $10.42
- DXCM $17.03
- Revenue Next Year
- VRSK $10.84
- DXCM $15.59
- P/E Ratio
- VRSK $37.90
- DXCM $53.04
- Revenue Growth
- VRSK 7.60
- DXCM 9.30
- 52 Week Low
- VRSK $245.08
- DXCM $57.52
- 52 Week High
- VRSK $322.92
- DXCM $93.25
- Technical
- Relative Strength Index (RSI)
- VRSK 25.85
- DXCM 42.30
- Support Level
- VRSK $261.42
- DXCM $75.39
- Resistance Level
- VRSK $273.83
- DXCM $77.84
- Average True Range (ATR)
- VRSK 5.31
- DXCM 2.51
- MACD
- VRSK -1.64
- DXCM -0.00
- Stochastic Oscillator
- VRSK 1.01
- DXCM 40.45
About VRSK Verisk Analytics Inc.
Verisk Analytics is a leading provider of data analytics and proprietary solutions supporting clients within the insurance ecosystem. Verisk operates under a single segment with two separate business units, underwriting and claims. Within underwriting, the company operates as both a statistical agent and advisory organization collecting and aggregating industrywide claims and policy data and providing insurers with pre-approved forms, rules, and loss costs. Aside from their regulatory and compliance offerings, Verisk provides specialized solutions utilized to power P&C underwriting and catastrophe risk assessment used in reinsurance and insurance-linked securities. Verisk's smaller claims business is critical in preventing fraud and estimating property insurance claims.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.